[
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
    "url": "https://finnhub.io/api/news?id=8631cc0b9f378ce4781a0d114e34ef978d7397f5afae03980e6caa81de8e6704",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758213300,
      "headline": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
      "id": 136868806,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
      "url": "https://finnhub.io/api/news?id=8631cc0b9f378ce4781a0d114e34ef978d7397f5afae03980e6caa81de8e6704"
    }
  },
  {
    "ts": null,
    "headline": "Hologic's Strong International Traction to Continue Despite Headwinds",
    "summary": "HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.",
    "url": "https://finnhub.io/api/news?id=99238d0bf59efe67b1da8599540cb94ecd0f55f040dd2a465057da44d964427b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758203760,
      "headline": "Hologic's Strong International Traction to Continue Despite Headwinds",
      "id": 136799579,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.",
      "url": "https://finnhub.io/api/news?id=99238d0bf59efe67b1da8599540cb94ecd0f55f040dd2a465057da44d964427b"
    }
  },
  {
    "ts": null,
    "headline": "US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux",
    "summary": "The United States Next Generation Sequencing (NGS) Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% between 2025 and 2033. Key drivers include rising demand for personalized medicine, agricultural advancements, and innovations in data analysis and automation. This market growth is bolstered by significant government funding and increasing NGS adoption in clinical diagnostics. Leading companies such as Illumina and Thermo Fishe",
    "url": "https://finnhub.io/api/news?id=ab56c92c0578114e55bd5ac8f6ac565da33b03411ada55cc970097fb22e71985",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758198420,
      "headline": "US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux",
      "id": 136797702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The United States Next Generation Sequencing (NGS) Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% between 2025 and 2033. Key drivers include rising demand for personalized medicine, agricultural advancements, and innovations in data analysis and automation. This market growth is bolstered by significant government funding and increasing NGS adoption in clinical diagnostics. Leading companies such as Illumina and Thermo Fishe",
      "url": "https://finnhub.io/api/news?id=ab56c92c0578114e55bd5ac8f6ac565da33b03411ada55cc970097fb22e71985"
    }
  }
]